• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. To evaluate the mucormycosis cases in post Covid-19 patients

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

To evaluate the mucormycosis cases in post Covid-19 patients

    Author

    • Dr. Snehanshu Shukla, Dr. Ranvijay Singh, Dr. Gaurav Kumar
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Aim: To evaluate the mucormycosis cases in post Covid-19 patients.
Methods: This cross-sectional observational study was carried out in the Department of
Microbiology. Basic microbiological methods such as gram stain and KOH smear were
used for the detection of MC in the received clinical specimen and morphology was seen
in the microscope. Patients admitted in our hospital with a history of fever, cough, body
ache and shortness of breath for 4-5 days with have positive report of nasopharyngeal/
oropharyngeal swab for covid19 RT-PCR were included in the present study.
Results: Age, sex and other demography details were collected before sample collection,
the average age of the participants was 60.4 ± 7.5 years and the majority of participants
were male 75%. Although, 45% participants belong to below 50 year age and 55% of
participant belongs to above 50 year age. Out of n=50 specimens, total 9 specimen found
positive for fungal smear i.e. n=6 sputum, n=3 nasal swabs and n=0 BAL specimens.
Conclusions: The present study concluded that the cases of life threatening MC increase
day by day in central India as post complication of covid-19 disease.

Keywords

  • Mucormycosis
  • post Covid-19 disease patients
  • XML
  • PDF 173.42 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 171
    • PDF Download: 178
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 3
February 2022
Page 134-138
Files
  • XML
  • PDF 173.42 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 171
  • PDF Download: 178

APA

Kumar, D. S. S. D. R. S. D. G. (2022). To evaluate the mucormycosis cases in post Covid-19 patients. European Journal of Molecular & Clinical Medicine, 9(3), 134-138.

MLA

Dr. Snehanshu Shukla, Dr. Ranvijay Singh, Dr. Gaurav Kumar. "To evaluate the mucormycosis cases in post Covid-19 patients". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 134-138.

HARVARD

Kumar, D. S. S. D. R. S. D. G. (2022). 'To evaluate the mucormycosis cases in post Covid-19 patients', European Journal of Molecular & Clinical Medicine, 9(3), pp. 134-138.

VANCOUVER

Kumar, D. S. S. D. R. S. D. G. To evaluate the mucormycosis cases in post Covid-19 patients. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 134-138.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus